Cas:83482-77-3 (3α,16α)-17,18-Didehydroeburnamenin-14-ylmethyl 3,4,5-trimethoxyb enzoate manufacturer & supplier

Chemical Name:(3α,16α)-17,18-Didehydroeburnamenin-14-ylmethyl 3,4,5-trimethoxyb enzoate

CAS.NO:83482-77-3

Synonyms:(3α,16α)-17,18-Didehydroeburnamenin-14-ylmethyl 3,4,5-trimethoxyb enzoate

Molecular Formula:C₃₀H₃₂N₂O₅

Molecular Weight:500.58500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:543.5ºC at 760 mmHg

Density:1.28g/cm3

Index of Refraction:1.633

PSA:62.16000

Exact Mass:500.23100

LogP:5.18190

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3α,16α)-17,18-Didehydroeburnamenin-14-ylmethyl 3,4,5-trimethoxyb enzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3α,16α)-17,18-Didehydroeburnamenin-14-ylmethyl 3,4,5-trimethoxyb enzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3α,16α)-17,18-Didehydroeburnamenin-14-ylmethyl 3,4,5-trimethoxyb enzoate Use and application,(3α,16α)-17,18-Didehydroeburnamenin-14-ylmethyl 3,4,5-trimethoxyb enzoate technical grade,usp/ep/jp grade.

Related News: For its part, the FDA’s representative at the meeting, Doran Fink, M.D., said the drug regulator is “working as rapidly as possible to conduct a thorough and comprehensive” review of all the COVID-19 vaccines that have applied for full approval. Pfizer and Moderna recently submitted their applications for a full nod. 2-thiophen-2-yl-ethenesulfonic acid (6-chloro-5-p-tolyl-pyrimidin-4-yl)-amide manufacturers The manufacturing chief pointed to some of the cutting-edge technology Takeda will roll out at the upgraded facility, such as automation and robotics, plus virtual reality equipment and training. Bis-{4-[(E)-benzylimino-methyl]-benzyl}-carbamic acid tert-butyl ester suppliers MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. (3.3.3-Trifluor-propyl)-vinyl-dimethylsilan vendor & factory Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. ,Lonza’s Nansha site is fully integrated within the company’s global manufacturing network. Scientists and engineers based in Nansha focus on API development and manufacturing for customers around the globe.